Bring new perspective to global medical care.


The cell and gene therapy market is growing at an exceptional rate globally. We started CELLIAN-BiCLO Incorporated to provide innovative solutions that meet appropriately the increasing needs for problem-solving in cell and gene therapy manufacturing and also to pursue global growth.

In addition, by creating new business, we aim to enrich people’s lives with making new job opportunities and to contribute to healthy longevity society.

 With the strong feeling that our services will lead to a new future of global medical care, we will continue to work on all the challenges and advance toward an even greater goal.


President & CEO Shin Kawamata

Shin Kawamata PROFILE

Completed Graduate School of Medicine (Pathology) Kyoto University in 1998, Medical Doctor, Hematologist. Following work as a postdoctoral researcher at the Stanford University School of Medicine, appointed as a senior researcher at the Institute of Biomedical Research and Innovation of the Foundation for Biomedical Research and Innovation at Kobe in 2002. Since 2015, Director of R&D Center for Cell Therapy of the Foundation for Biomedical Research and Innovation at Kobe. 

Company Name

CELLIAN-BiCLO Incorporated

Head Office

TRI 3F 1-5-4 Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047 Japan

Close to Iryo Center Station of Kobe Port Liner

View in Google Maps >>


JPY 10 million

Date of Foundation

February 2, 2022

Main Business

Development, sales, and service of cell manufacturing management software.

President & CEO

Shin Kawamata

Board member

Board member: Takahiro Hijioka
Board member (External): Mitsuru Miyata
Audit: Hiroki Yoshida